Search results
Results from the WOW.Com Content Network
Kernel is one of several companies researching links between the human brain and computer interfaces, including Neuralink, Precision Neuroscience, Synchron, and Facebook. [14] Kernel also offers neuroscience as a service to scientists and businesses, conducting subject testing at their office. [1]
Neuralink has developed an application-specific integrated circuit to create a 1,536-channel recording system. This system consists of 256 amplifiers that can be individually programmed, analog-to-digital converters within the chip, and peripheral circuit control to serialize the digitized information obtained.
Elon Reeve Musk (/ ˈ iː l ɒ n m ʌ s k /; born June 28, 1971) is a businessman known for his key roles in the space company SpaceX and the automotive company Tesla, Inc. He is also known for his ownership of X Corp. (the company that operates the social media platform X, formerly Twitter), and his role in the founding of the Boring Company, xAI, Neuralink, and OpenAI.
An animal testing laboratory at Elon Musk's Neuralink brain technology company was found to have "objectionable conditions or practices" by the Food and Drug Administration, which cited the ...
The FDA's breakthrough tag is given to certain medical devices that provide treatment or diagnosis of life-threatening conditions. The experimental device, known as Blindsight, "will enable even ...
Noland Arbaugh, the 29-year-old patient who was paralyzed below the shoulder after a diving accident, played chess on his laptop and moved the cursor using the Neuralink device. The implant seeks ...
Blindsight is being developed to enable individuals with total visual impairment due to damage to the optic nerve but with intact visual cortex to see, this is made possible by bypassing the optic nerve and directly stimulating the visual cortex to create a visual perception.
Neuralink did not immediately reply to Reuters' request for further details. The firm successfully implanted a chip on its first human patient last month, after receiving approval for human trial ...